Continental Investors Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Continental Investors Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$312K	Hold	2,316	–	–	0.29%	63
2025 Q4	$289K	Sell	2,316 -23	-1%	-$2.64K	0.37%	60
2025 Q3	$252K	Buy	+2,339	New	+$211K	0.37%	61
2025 Q1	–	Sell	-2,339	Closed	-$211K	–	65
2024 Q4	$211K	Buy	2,339 +1	+0%	+$97	0.42%	59
2024 Q3	$229K	Hold	2,338	–	–	0.47%	56
2024 Q2	$217K	Buy	2,338 +3	+0.1%	+$269	0.48%	58
2024 Q1	$219K	Hold	2,335	–	–	0.52%	55
2023 Q4	$209K	Buy	+2,335	New	+$173K	0.54%	53
2023 Q3	–	Sell	-4,670	Closed	-$391K	–	64
2023 Q2	$391K	Buy	+4,670	New	+$391K	0.46%	47
2022 Q2	–	Sell	-2,335	Closed	-$261K	–	49
2022 Q1	$261K	Hold	2,335	–	–	0.68%	36
2021 Q4	$210K	Buy	+2,335	New	+$282K	0.56%	47

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Continental Investors Services's XBI Position: Q1 2026 in Review

Continental Investors Services held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,316 shares worth $312K. The position accounts for 0.29% of the portfolio, ranked #63.

Continental Investors Services first reported a position in XBI in Q4 2021 and has held it in 11 quarters since. The position peaked at $391K in Q2 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Continental Investors Services held 2,316 shares of State Street SPDR S&P Biotech ETF worth $312K as of Q1 2026.
Continental Investors Services left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.29% of Continental Investors Services's portfolio in Q1 2026, its #63 holding.
Continental Investors Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 11 quarters since.
Continental Investors Services's State Street SPDR S&P Biotech ETF position peaked at $391K in Q2 2023.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Continental Investors Services's 13F filing for Q1 2026, filed 15 May 2026.